Illustration of a clinic building (not a photo of Dana-Farber Cancer Institute, Inc.)
Illustration

Michael Wagner, MD

Medical Oncology in Boston, MA

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • Offers telehealth
  • 15 years since graduation
  • Public record — not managed by the clinician

About Dr. Michael Wagner

Dr. Michael Wagner is a physician specializing in medical oncology practicing in Boston, MA, a graduate of Harvard Medical School (2011). Affiliated with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute and 1 more. Treated 106 Medicare patients in 2024.

Provider details

SpecialtyMedical OncologyOther medical oncology doctors in Boston
CredentialsMD
EducationHarvard Medical School, 2011CMS Doctors and Clinicians
GenderMale
NPI number1023317898National Provider Identifier (CMS NPPES), issued March 2011
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Dr. Michael Wagner's specialties and state licenses

  • Medical Oncology Primary
    License: MA 1016422
  • Medical Oncology
    License: WA MD60759395

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Michael Wagner practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Michael Wagner

  • Beth Israel Deaconess Medical CenterHospital · Boston, MA
  • Brigham and Women's HospitalHospital · Boston, MA
  • Dana-Farber Cancer InstituteHospital · Boston, MA
  • Wentworth-Douglass HospitalHospital · Dover, NH

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Michael Wagner's Medicare quality score (MIPS 2024)

84.1/100final MIPS score
65quality
100promoting interoperability
40improvement activities
69.1cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Michael Wagner's Medicare patients and services (2024)

106Medicare patients
254services billed
71average patient age
51%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more51$158.07
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes44$129.30
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more43$198.46
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more40$106.33
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes37$85.89

Common conditions among these patients

  • High blood pressure72%
  • High cholesterol67%
  • Cancer52%
  • Arthritis42%
  • Anxiety disorders37%
  • Chronic kidney disease30%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Michael Wagner (2025)

$4,135 in 5 general payments reported in 2025.

TypePaymentsAmount
Consulting fees4$3,555
Compensation for services other than consulting1$580

Paying companies: SpringWorks Therapeutics, Inc. ($3,555), Deciphera Pharmaceuticals Inc. ($580).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Dana-Farber Cancer Institute, Inc.

Questions about Dr. Michael Wagner

What kind of clinician is Dr. Michael Wagner?

Dr. Michael Wagner is listed as a physician specializing in medical oncology.

Where does Dr. Michael Wagner practice?

Dana-Farber Cancer Institute, Inc. at 450 Brookline Ave, Boston, MA 02215.

What is the NPI number of Dr. Michael Wagner?

The National Provider Identifier is 1023317898.

Does Dr. Michael Wagner accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Michael Wagner affiliated with?

Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Wentworth-Douglass Hospital.

Where did Dr. Michael Wagner go to medical school?

Harvard Medical School, graduating in 2011.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2023-10-19
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Visit the clinic page to see how to book.

Clinic page
0 clinics selected Compare